Protein Description

Gene Symbol HLA-E
Entrez ID 3133
Uniprot ID P13747
Description major histocompatibility complex, class I, E
Chromosomal Location chr6: 30,489,467-30,494,205
Ontology GO ID GO Term Definition Evidence

BP

GO:0001916

positive regulation of T cell mediated cytotoxicity

Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.

IDA

BP

GO:0002250

adaptive immune response

An immune response based on directed amplification of specific receptors for antigen produced through a somatic diversification process, and allowing for enhanced response to subsequent exposures to the same antigen (immunological memory).

IDA

BP

GO:0002474

antigen processing and presentation of peptide antigen via MHC class I

The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.

IBA|TAS

BP

GO:0002476

antigen processing and presentation of endogenous peptide antigen via MHC class Ib

The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.

IDA

BP

GO:0002479

antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent

The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.

TAS

BP

GO:0002480

antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent

The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.

TAS

BP

GO:0002715

regulation of natural killer cell mediated immunity

Any process that modulates the frequency, rate, or extent of natural killer cell mediated immunity.

IDA

BP

GO:0002717

positive regulation of natural killer cell mediated immunity

Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated immunity.

IDA

BP

GO:0019731

antibacterial humoral response

An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster.

IDA

BP

GO:0032736

positive regulation of interleukin-13 production

Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.

IDA

BP

GO:0032753

positive regulation of interleukin-4 production

Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.

IDA

BP

GO:0032759

positive regulation of TRAIL production

Any process that activates or increases the frequency, rate, or extent of TRAIL production.

IDA

BP

GO:0032760

positive regulation of tumor necrosis factor production

Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.

IDA

BP

GO:0036037

CD8-positive, alpha-beta T cell activation

The change in morphology and behavior of a CD8-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.

IDA

BP

GO:0042270

protection from natural killer cell mediated cytotoxicity

The process of protecting a cell from natural killer cell mediated cytotoxicity.

IDA

BP

GO:0045087

innate immune response

Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.

TAS

BP

GO:0050776

regulation of immune response

Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.

TAS

BP

GO:0050830

defense response to Gram-positive bacterium

Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.

IDA

BP

GO:0051024

positive regulation of immunoglobulin secretion

Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.

IDA

BP

GO:0060333

interferon-gamma-mediated signaling pathway

A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.

TAS

BP

GO:0060337

type I interferon signaling pathway

A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

TAS

BP

GO:2000566

positive regulation of CD8-positive, alpha-beta T cell proliferation

Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.

IDA

CC

GO:0000139

Golgi membrane

The lipid bilayer surrounding any of the compartments of the Golgi apparatus.

TAS

CC

GO:0005886

plasma membrane

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

TAS

CC

GO:0009986

cell surface

The external part of the cell wall and/or plasma membrane.

IDA

CC

GO:0012507

ER to Golgi transport vesicle membrane

The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi.

TAS

CC

GO:0030670

phagocytic vesicle membrane

The lipid bilayer surrounding a phagocytic vesicle.

TAS

CC

GO:0031901

early endosome membrane

The lipid bilayer surrounding an early endosome.

TAS

CC

GO:0032398

MHC class Ib protein complex

A transmembrane protein complex composed of a MHC class Ib alpha chain and, in most cases, an invariant beta2-microglobin chain, and with or without a bound peptide or lipid antigen. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.

IDA

CC

GO:0042612

MHC class I protein complex

A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.

IDA

CC

GO:0070062

extracellular exosome

A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.

IDA

CC

GO:0071556

integral component of lumenal side of endoplasmic reticulum membrane

The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane.

TAS

MF

GO:0005102

receptor binding

Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

IPI

MF

GO:0030881

beta-2-microglobulin binding

Interacting selectively and non-covalently with beta-2-microglobulin.

IDA|IMP

MF

GO:0042288

MHC class I protein binding

Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.

IDA

MF

GO:0042605

peptide antigen binding

Interacting selectively and non-covalently with an antigen peptide.

IDA|IMP

MF

GO:0046703

natural killer cell lectin-like receptor binding

Interacting selectively and non-covalently with a lectin-like natural killer cell receptor.

IPI

Domain ID Description

IPR001039

MHC class I alpha chain, alpha1 alpha2 domains

IPR003006

Immunoglobulin/major histocompatibility complex, conserved site

IPR003597

Immunoglobulin C1-set

IPR007110

Immunoglobulin-like domain

IPR010579

MHC class I, alpha chain, C-terminal

IPR011161

MHC class I-like antigen recognition-like

IPR011162

MHC classes I/II-like antigen recognition protein

IPR013783

Immunoglobulin-like fold

Pathway ID Pathway Term Pathway Source

hsa04144

Endocytosis

KEGG

hsa04145

Phagosome

KEGG

hsa04514

Cell adhesion molecules (CAMs)

KEGG

hsa04612

Antigen processing and presentation

KEGG

hsa04650

Natural killer cell mediated cytotoxicity

KEGG

hsa04940

Type I diabetes mellitus

KEGG

hsa05166

HTLV-I infection

KEGG

hsa05168

Herpes simplex infection

KEGG

hsa05169

Epstein-Barr virus infection

KEGG

hsa05203

Viral carcinogenesis

KEGG

hsa05320

Autoimmune thyroid disease

KEGG

hsa05330

Allograft rejection

KEGG

hsa05332

Graft-versus-host disease

KEGG

hsa05416

Viral myocarditis

KEGG

WP2328

Allograft Rejection

WikiPathways

WP183

Proteasome Degradation

WikiPathways

UMLS CUI UMLS Term

C0030491

Parapsoriasis

Tissue Cell Type

kidney

cells in glomeruli

lymph node

non-germinal center cells

tonsil

non-germinal center cells

No databases found.

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene Symbol Entrez ID Uniprot ID Score

HLA-E

3133

P13747

0.62

ABCA3

21

Q99758

0.63

ASPH

444

Q12797

0.63

COX5B

1329

P10606

0.63

ATF6B

1388

Q99941

0.63

EPHB4

2050

P54760

0.63

FCGRT

2217

P55899

0.63

GAS6

2621

Q14393

0.63

HLA-A

3105

P30443

0.63

HLA-DPB1

3115

P04440

0.63

HLA-F

3134

P30511

0.63

HLA-H

3136

P01893

0.63

MR1

3140

Q95460

0.63

NDST1

3340

P52848

0.63

ITGA6

3655

P23229

0.63

KCNJ8

3764

Q15842

0.63

MAN2A2

4122

P49641

0.63

MGAT5

4249

Q09328

0.63

RPL31

6160

P62899

0.63

TRAPPC2

6399

P0DI81

0.63

NEK4

6787

P51957

0.63

NDST2

8509

P52849

0.63

MADD

8567

Q8WXG6

0.63

FAM127A

8933

O15255

0.63

ECEL1

9427

O95672

0.63

EIF2AK3

9451

Q9NZJ5

0.63

ARFGEF2

10564

Q9Y6D5

0.63

FAM189B

10712

P81408

0.63

ATF6

22926

P18850

0.63

WDFY3

23001

Q8IZQ1

0.63

TMEM131

23505

Q92545

0.63

PLXNB2

23654

O15031

0.63

BACE2

25825

Q9Y5Z0

0.63

CNNM1

26507

Q9NRU3

0.63

METTL13

51603

Q8N6R0

0.63

PLXNA3

55558

P51805

0.63

EDEM2

55741

Q9BV94

0.63

PBXIP1

57326

Q96AQ6

0.63

GALNT12

79695

Q8IXK2

0.63

PTCD2

79810

Q8WV60

0.63

TCTN2

79867

Q96GX1

0.63

CNTNAP3

79937

Q9BZ76

0.63

PPP1R16A

84988

Q96I34

0.63

ATP23

91419

Q9Y6H3

0.63

TAP2

6891

Q03519

0.72

CALR

811

P27797

0.82

B2M

567

P61769

0.89

CD8A

925

P01732

0.52

KLRC1

3821

P26715

0.52

KLRC2

3822

P26717

0.62

AKT2

208

P31751

0.63

HLA-B

3106

P01889

0.63

HLA-C

3107

P30499

0.63

HERC2

8924

O95714

0.63

UBD

10537

O15205

0.63

KLRD1

3824

Q13241

0.86